Abstract. Hepatic lesions, experimentally-induced in Fisher 344 (F344) and Brown Norway (BN) rats, respectively, susceptible and resistant to liver carcinogenesis, progress differently to hepatocellular carcinoma (HCC). The mechanisms responsible for the acquisition of the resistant phenotype are not completely clear. Herein, we show that in F344 rats subjected to carcinogenic treatment, angiogenesis and DNA oxidation markers increase in preneoplastic and neoplastic liver lesions. On the contrary, in the HCCs of treated BN rats, angiogenesis and a minor DNA oxidation are accompanied by an attempt of tissue remodelling. This study suggests that DNA oxidation might be an important factor in the initiation and promotion of the events of hepatocarcinogenesis. On the other hand, the enhancement of GSH levels and the down-regulation of superoxide dismutase (SOD) expression in both rat strains suggest that antioxidant response is not involved in the acquisition of resistant phenotype.
Introduction
Liver carcinogenesis is a multi-stage process (1) and several experimental models have been used to study the different steps of hepatocellular carcinoma (HCC) progression. Recently, it has been demonstrated that Fisher 344 (F344) and Brown Norway (BN) rats progress differently to HCC (2) . In F344 animals, neoplastic lesions are characterised by rapid growth and progression to more malignant stages whereas the majority of lesions in BN rats grow very slowly and do not progress to full malignancy. Thus, inter-strain comparison of the different lesions could give insight into the relationships between molecular features and tumour progression rate.
Important studies have shown an association between hepatocarcinogenesis and oxidative DNA damage by demonstrating the suppression of carcinogenesis upon the administration of antioxidant therapies (3, 4) . 8-Hydroxy-2'-deoxyguanosine (8-OHdG) is a good marker of DNA oxidation and has been demonstrated to be implicated in hepatocarcinogenesis (5) .
Cellular glutathione (GSH) and related enzymes work as the main antioxidant protective mechanisms against reactive oxygen species (ROS) and free radicals (6) and changes in GSH metabolism have been implicated in tumour progression (7) . Copper-zinc superoxide dismutase (Cu, Zn-SOD; SOD1) and manganese containing SOD (Mn-SOD; SOD2) synergize with the GSH redox system in order to provide cellular defence (8) .
The aim of the present study was to monitor the presence of 8-OHdG in the foci of altered hepatocytes, preneoplastic and neoplastic nodules in F344 and BN rat strains. Furthermore, following the steps of experimentallyinduced HCC, the levels of GSH and SOD as parameters of the antioxidant status, are to be determined.
Materials and methods
Liver samples. Frozen-stored liver samples were kindly provided by Professor F. Feo (University of Sassari, Italy). In the laboratory of Professor Feo, male Wistar F344 and BN rats were treated with DENA/AAF/partial hepatectomy (9), according to the 'resistant hepatocyte' (RH) protocol (10) .
Histology. Frozen livers of F344 and BN rats were sectioned (5 μm) on a cryostat (Leica Microsystems AG, Wetzlar, Germany), placed on microscope polylysine coated slides, fixed in 10% formalin and stained with hematoxylin and eosin.
Analyses of apoptotic nuclei in liver cryosections were performed by TdT-FragEL TM DNA fragmentation detection kit (Calbiochem, La Jolla, CA). Briefly, frozen liver sections were fixed in 4% paraformaldehyde and permeabilised with 2 mg/ml Proteinase K in 10 Reduced and oxidized glutathione levels. Liver homogenate was prepared in ice-cold lysis buffer containing 154 mM KCl, 5 mM diethylenetriaminepentaacetic acid (DTPA) and 0.1 M potassium phosphate buffer, pH 6.8. An aliquot was removed for the determination of protein concentration (Lowry method). Subsequently, one volume of cold acid buffer containing 40 mM HCl, 10 mM DTPA, 20 mM ascorbic acid, and 5% trichloracetic acid (TCA), was added to one volume of homogenate. The suspension was centrifuged at 14000 x g and the resulting supernatant was centrifuged through a 0.45 μm microcentrifuge filter, yielding a 5% deproteinised homogenate, in which GSH and GSSG contents were determined by reaction with o-phthalaldehyde (OPA) (11) . Standard solutions were prepared by dissolving GSH or GSSG in Redox Quenching Buffer (RQB) containing 20 mM HCl, 5 mM DTPA and 10 mM ascorbic acid. Deproteinised homogenate, or standards (GSH or GSSG), were treated with 5% TCA-RQB solution. To evaluate GSSG levels, N-ethylmaleimide (7.5 mM in RQB) was added. Subsequently, 1 M potassium phosphate (KP i ) buffer (pH 7.0) was added to all tubes and the samples were incubated for 5 min at room temperature. For GSSG assay 100 mM dithionite-RQB was used and the homogenates were incubated for 60 min at room temperature. Then, 0.1 M KP i buffer (pH 6.9) and OPA (5 mg/ml in methanol) were added and, after a 30-min incubation at room temperature, sample fluorescence was monitored with a Perkin Elmer fluorimeter (Perkin Elmer Life and Analytical Sciences, Shelton, USA) at 365/430 nm.
Immunoblot analysis. Liver samples from F344 and BN rats were homogenised in lysis buffer containing 10 mM Hepes, 0.25 M sucrose, 5 M EDTA, 10 mM ß mercaptoethanol, 0.3% Triton X-100, 0.3% protease inhibitors.
Immunoblots were carried out according to standard methods, using polyclonal rabbit anti-SOD1 and monoclonal mouse anti-SOD2 (AbCam, Cambridgeshire, UK); monoclonal mouse anti-ß-actin (Sigma); anti-mouse and antirabbit secondary antibodies coupled to horseradishperoxidase (Amersham International, Buckinghamshire, UK). Proteins were visualised with an enzyme-linked chemiluminescence detection kit according to the manufacturer's instructions (Amersham). Chemiluminescence was monitored by exposure to film and the signals were analysed, under non-saturating conditions, with an image densitometer connected to Quantity One software (BioRad laboratories, Hercules, CA, USA).
Data analysis.
Results were expressed as mean ± SD from at least three independent experiments. The statistical significance of parametric differences among sets of experimental data was evaluated by one-way ANOVA and Bonferroni's test for multiple comparisons.
Results
Microscopy analysis of hematoxylin-eosin stained liver sections of rats showed a progressive reduction of liver parenchyma which, in F344 rats, was already appreciated at 4 weeks from the tumorigenic treatment. Impressively, after 54 weeks, the characteristic liver parenchyma structure was totally destroyed. In BN rats, atrophy of the hepatic tissue started at 8 weeks whereas a partial attempt of remodelling was evident at 60 weeks (Fig. 1A) . 1B shows a different behaviour of microvessel density in preneoplastic and neoplastic lesions in F344 and BN rats. Notably, microvessel density, evaluated as immunofluorescent staining with anti-VEGF, was clearly lower in BN than F344 rat lesions already at 8 weeks.
On the basis of these observations, we determined the effect of the tumorigenic input with regard to apoptosis and DNA oxidative damage. F344 and BN liver sections (stained as described in Materials and methods) indicated a massive presence of apoptotic nuclei already at 4 weeks, with a progressive increase up to 54 and 60 weeks (Fig. 2A) .
8-OHdG immunoreactivity in F344 liver samples was already evident at 4 weeks, thereafter increasing in a timedependent manner. In BN livers, the fluorescence of 8-OHdG was observed only at 60 weeks (Fig. 2B) .
The content of hepatic GSH increased in treated F344 rats by 34 and 40%, respectively at 4 and 6 weeks, reaching a 2-fold induction at 54 weeks (Fig. 3A) . In BN rats, an increase of GSH by 73% was observed at 60 weeks (Fig. 3B) . No changes in GSSG levels were observed in either rat strain at any time point (data not shown).
Expression levels of SOD1 and SOD2 were comparable in F344 and BN liver lesions and were down-regulated at 54 and 60 weeks, respectively. In particular, SOD1 content decreased by 24 and 63% in neoplastic lesions of F344 and BN rats (Fig. 4A) . Similarly, SOD2 decreased by 27 and 45%, respectively, in F344 and BN liver lesions (Fig. 4B) . 
Discussion
Fisher 344 (F344) and Brown Norway (BN) rat strains have been demonstrated to be, respectively, susceptible and resistant to hepatocarcinogenesis induced by treatment with DENA/ AAF/partial hepatectomy (9) . The resistant phenotype of BN rat strain essentially depends on the incapacity of preneoplastic cells to grow autonomously and evolve to malignancy, associated with a high re-differentiation rate (12) . The mechanisms responsible for the acquisition of the resistant phenotype are not completely clear. In our study, HCC progression is accompanied by the increased expression of VEGF, a crucial regulator of angiogenesis (13) . Immunofluorescence analysis shows that the process of new blood vessel formation is less marked in hepatic tissue of BN rats.
It has been demonstrated that the status of hypoxia, which characterises tumour formation, can stimulate the induction of VEGF which, in turn, stimulates NADPH oxidase to produce reactive oxygen species (ROS) (14) . In chronic hepatitis C, infiltration of activated phagocytic cells provides an additional source of ROS production that promotes oxidative stress and damage to proteins, lipids and DNA (15) . Recently, it has been shown that oxidative DNA damage is associated with the increased risk of HCC and that hepatic 8-OHdG levels are considered useful markers to identify high-risk patients (16, 17) . Depending on the extent of DNA damage, cells may undergo apoptosis or proliferate towards tumour progression. The present study indicates that in F344 rat liver lesions, the 8-OHdG positivity, symptom of DNA oxidative damage, is paralleled by the presence of apoptotic nuclei.
On the other hand, in resistant BN rats, apoptosis is observed during all stages of induction, while DNA oxidation is observed only at 60 weeks, accompanied by attempts of tissue remodelling.
In our context, however, the presence of 8-OHdG and apoptosis in hepatic lesions does not correlate with a depletion of antioxidant GSH, commonly observed in apoptosis (18) . The observed enhancement of the GSH content could be interpreted as the liver attempting to counteract the oxidative stress induced by the treatment. Alternatively, it could be attributed to the pleiotropic effects of GSH which controls the onset of tumour cell proliferation (19, 20) and is implicated in the detoxification of a wide variety of compounds (21) .
Indeed, over-production of GSH has been reported in human cancer (22) and, in line with our findings, Navarro and collaborators also observed that GSH and ROS levels are higher in cancer cells that proliferate actively while GSSG levels remain constant during tumour promotion (23) . SOD-1 and SOD-2, respectively cytosolic and mitochondrial antioxidant enzymes, have a variable profile in cancer cells and in particular SOD-2 has been observed to diminish in most tumours compared to the corresponding normal tissues (24) (25) (26) . Similarly, in our study, the expression levels of SOD1 and SOD2 are importantly down-regulated in neoplastic liver lesions of F344 and BN rats.
Taken as a whole, this study suggests that DNA oxidation might be a necessary step for the progression from dysplastic nodules to HCC. On the other hand, the presence of apoptosis, the enhancement of GSH levels and the down-regulation of SOD expression in both rat strains suggest that neither apoptosis or alterations of the antioxidants, are involved in the acquisition of resistant phenotype. These findings are in line with relevant studies that exclude apoptosis as a mechanism of resistance, attributing a prominent role to re-differentiation (9) . In our study, this hypothesis might be supported by a lower DNA oxidative damage detected in neoplastic liver lesions of BN rats. In fact, sound and appreciated literature has hinted that low ROS levels can function as signalling molecules in cell differentiation (27) .
However, to better define the correlation between DNA oxidative damage and tumour progression, further studies in hepatocellular carcinoma cell models are required.
